Search

Author/Creator Vande Casteele, Niels

2. An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases. Issue 9 (September 2015)

Authors:
Van Stappen, Thomas; Billiet, Thomas; Vande Casteele, Niels; Compernolle, Griet; Brouwers, Els; Vermeire, Séverine; Gils, Ann
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 9(2015:Sep.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial. Issue 7 (10th April 2015)

Authors:
Baert, Filip; Kondragunta, Venkateswarlu; Lockton, Steven; Vande Casteele, Niels; Hauenstein, Scott; Singh, Sharat; Karmiris, Konstantinos; Ferrante, Marc; Gils, Ann; Vermeire, Séverine
Journal:
Gut
Issue:
Volume 65:Issue 7(2016)
Page Start:
1126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease – What the Clinician Needs to Know. (24th September 2021)

Authors:
Chen, David; Fulmer, Clifton; Gordon, Ilyssa O; Syed, Sana; Stidham, Ryan W; Vande Casteele, Niels; Qin, Yi; Falloon, Katherine; Cohen, Benjamin L; Wyllie, Robert; Rieder, Florian
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16:Number 3(2022)
Page Start:
460
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. (November 2020)

Authors:
Holmer, Ariela K.; Battat, Robert; Dulai, Parambir S.; Vande Casteele, Niels; Nguyen, Nghia; Jain, Anjali; Miralles, Ara; Neill, Jennifer; Le, Helen; Singh, Siddharth; Rivera-Nieves, Jesus; Sandborn, William J.; Boland, Brigid S.
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 13(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. (November 2020)

Authors:
Holmer, Ariela K.; Battat, Robert; Dulai, Parambir S.; Vande Casteele, Niels; Nguyen, Nghia; Jain, Anjali; Miralles, Ara; Neill, Jennifer; Le, Helen; Singh, Siddharth; Rivera-Nieves, Jesus; Sandborn, William J.; Boland, Brigid S.
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 13(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Issue 2 (10th January 2019)

Authors:
Battat, Robert; Dulai, Parambir S; Vande Casteele, Niels; Evans, Elisabeth; Hester, Kelly D; Webster, Edvelyn; Jain, Anjali; Proudfoot, James A; Mairalles, Ara; Neill, Jennifer; Singh, Siddharth; Chang, John T; Rivera-Nieves, Jesus; Sandborn, William J; Boland, Brigid S
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 2(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Issue 2 (5th October 2018)

Authors:
Battat, Robert; Dulai, Parambir S; Vande Casteele, Niels; Evans, Elisabeth; Hester, Kelly D; Webster, Edvelyn; Jain, Anjali; Proudfoot, James A; Mairalles, Ara; Neill, Jennifer; Singh, Siddharth; Chang, John T; Rivera-Nieves, Jesus; Sandborn, William J; Boland, Brigid S
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 2(2019)
Page Start:
410
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗